Clinical Trial Update: Efficacy and Safety of VB119 in Subjects With Membranous Nephropathy [Phase 1, Phase 2]

View source ↗

Summary

The update reports on the efficacy and safety of VB119 in membranous nephropathy across Phase 1/2, but the trial was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Membranous Nephropathy

Drugs mentioned

• VB119

Snippet

Sponsor: Tenet Medicines | Conditions: Membranous Nephropathy | Phase 1, Phase 2 | Status: TERMINATED